GlaxoSmithKline's total assets for Q1 2026 were £82.91B, an increase of 35.89% from the previous quarter. GSK total liabilities were £59.93B for the fiscal quarter, a 33.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.